Coombs Geoffrey W, Nimmo Graeme R, Bell Jan M, Huygens Flavia, O'Brien Frances G, Malkowski Mary J, Pearson Julie C, Stephens Alex J, Giffard Philip M
Gram-Positive Bacteria Typing and Research Unit, Royal Perth Hospital, Australia.
J Clin Microbiol. 2004 Oct;42(10):4735-43. doi: 10.1128/JCM.42.10.4735-4743.2004.
Increasing reports of the appearance of novel nonmultiresistant methicillin-resistant Staphylococcus aureus MRSA (MRSA) strains in the community and of the spread of hospital MRSA strains into the community are cause for public health concern. We conducted two national surveys of unique isolates of S. aureus from clinical specimens collected from nonhospitalized patients commencing in 2000 and 2002, respectively. A total of 11.7% of 2,498 isolates from 2000 and 15.4% of 2,486 isolates from 2002 were MRSA. Approximately 54% of the MRSA isolates were nonmultiresistant (resistant to less than three of nine antibiotics) in both surveys. The majority of multiresistant MRSA isolates in both surveys belonged to two strains (strains AUS-2 and AUS-3), as determined by pulsed-field gel electrophoresis (PFGE) and resistogram typing. The 3 AUS-2 isolates and 10 of the 11 AUS-3 isolates selected for multilocus sequence typing (MLST) and staphylococcal chromosomal cassette mec (SCCmec) analysis were ST239-MRSA-III (where ST is the sequence type) and thus belonged to the same clone as the eastern Australian MRSA strain of the 1980s, which spread internationally. Four predominant clones of novel nonmultiresistant MRSA were identified by PFGE, MLST, and SCCmec analysis: ST22-MRSA-IV (strain EMRSA-15), ST1-MRSA-IV (strain WA-1), ST30-MRSA-IV (strain SWP), and ST93-MRSA-IV (strain Queensland). The last three clones are associated with community acquisition. A total of 14 STs were identified in the surveys, including six unique clones of novel nonmultiresistant MRSA, namely, STs 73, 93, 129, 75, and 80slv and a new ST. SCCmec types IV and V were present in diverse genetic backgrounds. These findings provide support for the acquisition of SCCmec by multiple lineages of S. aureus. They also confirm that both hospital and community strains of MRSA are now common in nonhospitalized patients throughout Australia.
社区中新型非多重耐药性耐甲氧西林金黄色葡萄球菌(MRSA)菌株出现的报告日益增多,以及医院MRSA菌株传播至社区,这引发了公共卫生方面的关注。我们分别于2000年和2002年对从非住院患者临床标本中分离出的独特金黄色葡萄球菌菌株进行了两项全国性调查。2000年的2498株分离菌中有11.7%为MRSA,2002年的2486株分离菌中有15.4%为MRSA。在两项调查中,约54%的MRSA分离菌为非多重耐药性(对九种抗生素中的不到三种耐药)。通过脉冲场凝胶电泳(PFGE)和耐药谱分型确定,两项调查中大多数多重耐药性MRSA分离菌属于两个菌株(菌株AUS - 2和AUS - 3)。为进行多位点序列分型(MLST)和葡萄球菌染色体盒式mec(SCCmec)分析而选择的3株AUS - 2分离菌和11株AUS - 3分离菌中的10株为ST239 - MRSA - III(其中ST为序列类型),因此与20世纪80年代在国际上传播的澳大利亚东部MRSA菌株属于同一克隆。通过PFGE、MLST和SCCmec分析鉴定出四种主要的新型非多重耐药性MRSA克隆:ST22 - MRSA - IV(菌株EMRSA - 15)、ST1 - MRSA - IV(菌株WA - 1)、ST30 - MRSA - IV(菌株SWP)和ST93 - MRSA - IV(菌株昆士兰)。后三个克隆与社区获得性感染相关。调查中共鉴定出14种序列类型,包括六种新型非多重耐药性MRSA的独特克隆,即序列类型73、93、129、75和80slv以及一种新的序列类型。SCCmec IV型和V型存在于不同的遗传背景中。这些发现为金黄色葡萄球菌的多个谱系获得SCCmec提供了支持。它们还证实,MRSA的医院菌株和社区菌株目前在澳大利亚各地的非住院患者中都很常见。